Apimeds Pharmaceuticals US, Inc. (APUS)

APUS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	22	-	-	-	-
Enterprise Value	23	-	-	-	-
Debt / Equity Ratio	-0.55	-0.50	8.38	-0.96	-1.68
Quick Ratio	0.14	0.00	3.33	0.02	16.09
Current Ratio	0.15	0.01	3.42	0.02	16.16
Return on Assets (ROA)	-409.38%	-366.30%	-218.17%	-448.25%	-
Return on Capital (ROIC)	-	-	-348.55%	-611.12%	-
Buyback Yield / Dilution	-40.82%	-71.89%	-19.55%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q